Nuveen Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.79M | Sell |
141,298
-22,400
| -14% | -$284K | ﹤0.01% | 2432 |
|
|
2024
Q3 | $2.28M | Sell |
163,698
-27,208
| -14% | -$379K | ﹤0.01% | 2346 |
|
|
2024
Q2 | $2.63M | Buy |
190,906
+15,131
| +9% | +$209K | ﹤0.01% | 2249 |
|
|
2024
Q1 | $2.9M | Hold |
175,775
| – | – | ﹤0.01% | 2229 |
|
|
2023
Q4 | $2.57M | Sell |
175,775
-249,434
| -59% | -$3.64M | ﹤0.01% | 2295 |
|
|
2023
Q3 | $5.22M | Buy |
425,209
+72,443
| +21% | +$889K | ﹤0.01% | 1846 |
|
|
2023
Q2 | $4.21M | Sell |
352,766
-146,025
| -29% | -$1.74M | ﹤0.01% | 2001 |
|
|
2023
Q1 | $6.67M | Buy |
498,791
+77,664
| +18% | +$1.04M | ﹤0.01% | 1727 |
|
|
2022
Q4 | $2.79M | Sell |
421,127
-27,643
| -6% | -$183K | ﹤0.01% | 2236 |
|
|
2022
Q3 | $2.97M | Buy |
448,770
+376,218
| +519% | +$2.49M | ﹤0.01% | 2183 |
|
|
2022
Q2 | $481K | Buy |
72,552
+32,778
| +82% | +$217K | ﹤0.01% | 3024 |
|
|
2022
Q1 | $391K | Buy |
39,774
+24,813
| +166% | +$244K | ﹤0.01% | 3072 |
|
|
2021
Q4 | $260K | Hold |
14,961
| – | – | ﹤0.01% | 3197 |
|
|
2021
Q3 | $355K | Buy |
+14,961
| New | +$355K | ﹤0.01% | 3227 |
|